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StimulantsThe forced swim test (FST) is a preclinical test to the screening of antidepressants based on rats or mice be-
haviours, which is also sensitive to stimulants of motor activity. This work standardised and validated a
method to register the active and passive behaviours of Swiss mice during the FST in order to strength the
speciﬁcity of the test. Adult male Swiss mice were subjected to the FST for 6 min without any treatment or
after intraperitoneal injection of saline (0.1 ml/10 g), antidepressants (imipramine, desipramine, or ﬂuoxe-
tine, 30 mg/kg) or stimulants (caffeine, 30 mg/kg or apomorphine, 10 mg/kg). The latency, frequency and
duration of behaviours (immobility, swimming, and climbing) were scored and summarised in bins of 6, 4,
2 or 1 min. Parameters were ﬁrst analysed using Principal Components Analysis generating components pu-
tatively related to antidepressant (ﬁrst and second) or to stimulant effects (third). Antidepressants and stim-
ulants affected similarly the parameters grouped into all components. Effects of stimulants on climbing were
better distinguished of antidepressants when analysed during the last 4 min of the FST. Surprisingly, the ef-
fects of antidepressants on immobility were better distinguished from saline when parameters were scored
in the ﬁrst 2 min. The method proposed here is able to distinguish antidepressants from stimulants of motor
activity using Swiss mice in the FST. This reﬁnement should reduce the number of mice used in preclinical
evaluation of antidepressants.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
The forced swim test (FST) in rats or mice is pre-clinically employed
to evaluate drugs being screened for putative antidepressant activity
(Castagné et al., 2009; Porsolt et al., 1977, 1978). The FST is quick test
to run, very reliable across laboratories, sensitive, and relatively selec-
tive for antidepressant drugs (Cryan et al., 2005; Petit-Demouliere et
al., 2005). The original protocol of the FST (Porsolt et al., 1977, 1978)
consisted of placing the animal into a receptacle ﬁlled with water
once (mice) or twice (rats) while recording the amount of time spent
in a posture of immobility.Mice or rats, after 2 min of vigorous struggle,
adopted a typical posture of immobility (ﬂoating in the water makingOutbred Strain of mice from
Animal Use; C57Bl6/J, Inbred
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I, Outbred strain of mice from
tive Reuptake Inhibitors; PCA,
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siológicas, Universidade Federal
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ira).
rights reserved.only the slight movements necessary to keep the head above the
water), alternated with swimming or paddling movements (Porsolt et
al., 1977, 1978). This stress-induced failure in escape performance was
named “behavioural despair” and has been consistently prevented by
the treatment of rats or mice with different types of antidepressants
(Porsolt et al., 1977, 1978).
Modiﬁcations of the catalogued behaviours, scoring methods and
protocols have improved the predictive validity of the FST in rats
(Borsini et al., 1989; Cryan et al., 2005; Dal-Zotto et al., 2000; Detke et
al., 1997) and could suggest an approach to develop a more robust FST
in mice. A main modiﬁcation of the FST in rats was the analysis of active
behaviours in addition to immobility (Cryan et al., 2005; Detke et al.,
1997; Lucki, 1997; Vieira et al., 2008). Indeed, it was reported that anti-
depressants in general reduced rats' immobility posture, whereas nor-
epinephrine selective reuptake inhibitors of (NSRIs) increased climbing
and selective serotonin reuptake inhibitors (SSRIs) increased swimming
(e.g. Detke et al., 1997). These changes of the FST in rats enabled discrim-
ination between different types of antidepressants (Cryan et al., 2005;
Detke et al., 1997; Lucki, 1997). Moreover, in rats a tricyclic antidepres-
sant increased theduration of climbing,whereas a stimulant ofmotor ac-
tivity (caffeine) increased the frequency of climbing (Lino-de-Oliveira et
al., 2005; Vieira et al., 2008). These changes of the FST in rats enabled ex-
clusion of the confounding effects of motor stimulants in FST itself
(Kitada et al., 1981; Lino-de-Oliveira et al., 2005; Vieira et al., 2008). In
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study several potential antidepressant compounds and to develop hy-
potheses about their mechanisms of action (Nguyen et al., 2013;
Perona et al., 2008; Sanmukhani et al., 2011; Szewczyk et al., 2009).
The speciﬁcity for the effects of antidepressants in the FST in mice has
been veriﬁed only by an additional open ﬁeld test to discard motor con-
founds (David et al., 2003; Lucki, 1997; Petit-Demouliere et al., 2005).
Improvement of the FST in mice might facilitate the study of relevant
new molecular targets of potential antidepressants because genetically
engineered strains (transgenic or knockouts, e.g. Easton et al., 2003) are
more often available in this animal species than they are in rats. A com-
prehensive reviewof the FST inmice (Petit-Demouliere et al., 2005)men-
tioned a number of procedural aspects that should be taken into account
to accurately employ the test. Experimental alterations in cylinder diam-
eter, water depth, water temperature, the interval between treatment
and test, the treatment schedule and scoring methods are all sources of
data variability and inter-laboratory variation (Petit-Demouliere et al.,
2005). Housing conditions (enrichment or isolation (Guo et al., 2004;
Voikar et al., 2005; Xu et al., 2009), circadian rhythm (Easton et al.,
2003), dietary factors (restriction or ad libitum) or previous experience
in the cylinder (e.g. Alcaro et al., 2002) modify the behaviour of the
mice. In addition, animal-speciﬁc characteristics such as gender (Guo et
al., 2004), age (David et al., 2001) and strain (Alcaro et al., 2002; David
et al., 2003; Lucki et al., 2001) affect the amount of time spent immobile
and therefore affect the evaluation of antidepressant effects. In contrast to
the unpredictable responses across inbred strains, treatmentwith a range
of different antidepressants reduces the immobility of Swiss or
Swiss-derived mice (see, e.g., CD-1 and NMRI) during the FST (David et
al., 2003; Lucki et al., 2001; Petit-Demouliere et al., 2005), indicating
that this strain is valuable for the preclinical selection of monoaminergic
antidepressants (Bourin et al., 2005). Indeed, applying the FST in Swiss
mice was suggested as the ﬁrst step in investigating new potent antide-
pressant drugs before searching for downstream mechanisms of action
(Bourin et al., 2005).
Hence, the main aim of the present work was to characterise the
temporal and factorial proﬁle of active and passive behaviours of male
Swiss mice in the FST to identify variables useful in discriminating be-
tween different antidepressants and to distinguish them from stimu-
lants of motor activity. If the scorings of active and passive behaviours
during the FST explained most of the variability in the response of
Swiss mice to drug treatment, it would be possible to use them to dis-
criminate between drugs. Therefore, the effects of antidepressants
(imipramine, desipramine, and ﬂuoxetine) and stimulants of motor ac-
tivity (caffeine and apomorphine) on several passive and active behav-
iours of Swiss mice during the FST were compared. In addition,
behavioural latencies were recorded because, in NMRI and C57BL6/J
mice, latency to immobility seems to be a useful parameter for differen-
tiating antidepressants from stimulants of motor activity (Castagné et
al., 2009).2. Methods
2.1. Animals
Male Swiss mice, 90 days old, were kept in groups of 10 per cage
(33 cm × 40 cm × 18 cm) under controlled lighting (12 h light/dark
cycle with lights on at 07:00 am) and temperature (22 ± 2 C) condi-
tions with free access to food and water, except during the behavioural
test. The animals were provided by UFSC animal facilities. All experi-
ments were carried out in accordance with the principles of ethics and
animal welfare recommended by Brazilian Law (# 11.794 — 10/08/
2008) and the procedures approved by the local Ethics Committee on
Animal Use (CEUA/UFSC # 23080.024594/2010-87). All efforts were
made to minimise suffering and to reduce the number of animals used
in the experiments.2.2. Experimental design: descriptive behaviour analysis during the FST
(Experiment 1) and the effects of antidepressants on Swiss mice during
FST (Experiment 2)
In Experiment 1, the FST (Duarte et al., 2006, 2007; Gavioli et al.,
2003a, 2003b; Hellion-Ibarrola et al., 2008; Herrera-Ruiz et al., 2006)
consisted of individually placing the mouse into a cylindrical tank
(height 18.5 cm, diameter 12.5 cm) containing clean water at 25 C
(13.5 cm deep). After the test (6 min), the mice were taken out of the
water and allowed to dry under a lamp (40 W, 15 min) before being
returned to their home cages. The experimental room was illuminated
by indirect red light (15 W). The FST took place between 1:00 and
6:00 p.m. All test sessions were videotaped using an infrared video
camera (GeoVision Inc. GV-800 system, Taipei, Taiwan) located 20 cm
above the tank, to enable subsequent evaluation of the latency, frequen-
cy of episodes and amount of time spent in swimming, climbing and im-
mobility. Latency was deﬁned as the amount of time that elapsed
between placing themouse in the tank and the ﬁrst instance of each be-
havioural occurrence. Frequencies represent the number of incidences
of each type of behaviour, while duration reﬂects the total time spent
in all bouts of that behaviour within a given period. Immobility was de-
ﬁned as a lack of motion of the whole body, when mice ceased strug-
gling and remained ﬂoating motionless in the water, making only
those movements necessary to keep the head above water. Swimming
was recorded when large and horizontal movements of the forepaws
were performed, leading to displacement of the body around the cylin-
der. Climbing was recorded when vigorous vertical movements of the
forepaws, directed against the wall of the tank, were displayed, leading
to displacement the body around the cylinder. These parameters were
recorded and summarised in either one block of 6 min (i.e., the total
time of the test), or in one block of 4 min (i.e. the last 4 of the test as pre-
viously proposed, e.g. (Petit-Demouliere et al., 2005) or in the
remaining block of 2 min (the ﬁrst 2 min of the test). An additional
minute-by-minute description provided a temporal distribution of
each parameter and was analysed using a MANOVA (p b 0.05).
In Experiment 2, mice were tested in the FST (as described before)
30 min after intraperitoneal (i.p.) treatment with saline (NaCl 0.9%,
0.1 ml/10 g of body weight), antidepressant drugs (imipramine, desip-
ramine, and ﬂuoxetine, 30 mg/kg) or caffeine (30 mg/kg) (n = 10
mice/group). These doses were chosen according to the literature
(Bernardi et al., 1989; Steru et al., 1987; O'Neill et al., 1996; Rodrigues
et al., 2002). The behavioural parameters were recorded by experi-
menters blind to treatment and are summarised as follows: in one
block of 6 min, in one block of the last 4 min, in one block of the ﬁrst
2 min, or minute-by-minute.
2.3. Statistical analysis
2.3.1. Principal components analysis
Parameters summarised in one block of 6 min of Experiment 1were
submitted to Principal Components Analysis (PCA) followed by orthog-
onal Varimax rotation (Statistical Package®, 1995) was performed as
published by (Espejo, 1997; Lino-de-Oliveira et al., 2005; Mezadri et
al., 2011). A component was deﬁned by an Eigenvalue greater than
one. Eigenvectors (EVs) of ±1 indicate a perfect correlation of the var-
iable with the component. EV values ranging from ±0.40 to ±0.60 in-
dicate a moderate correlation, and values lower than ±0.40 indicate a
poor correlation. On the basis of the EV values (EV > ±0.4), variables
were divided into groups of putatively similar parameters. Positive
EVs indicate that a behavioural parameter correlates with the corre-
sponding component. A negative EV value indicates that the behaviour-
al variable is inversely correlated with the component. Multivariate
analysis requires the number of animals to be at least three times the
number of variables. Therefore, PCAwas applied only on the data of Ex-
periment 1. Shapiro–Wilk'sWand Levene's testswere used to check the
normality and the homogeneity of variance, respectively.
Fig. 1. Duration (in seconds) of the immobility, swimming and climbing recorded in the
6-min test session (A) or in the last for 4-min test session (B) or ﬁrst 2-min test session
of Swiss mice-FST after the acute treatment (n = 10/group) with saline (white bars), or
imipramine (light grey bars), desipramine (grey bars), ﬂuoxetine (dark grey bars) or caf-
feine (black bars). Bars representmean ± S.E.M.One-wayANOVA followed by Bonferroni's
test, ⁎p b 0.05 in comparison to saline group.
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Data collected during the 6-, 4-, or 2-min blockswere analysed using
a 1-way ANOVA followed by Bonferroni's post hoc test (p b 0.05, inde-
pendent factor: Treatment). Minute-by-minute data were analysed
using a 2-way ANOVA with repeated measures (p b 0.05, independent
factors: Treatment and Time) followed by Bonferroni's post hoc test
(p b 0.05). Latencies were analysed by the Kruskal–Wallis test
(p b 0.05) followed by Dunn's test (p b 0.05). Videotapes of adult
male Swiss mice in FST after treatment with apomorphine (10 mg/kg,
n = 12) or saline (0.1 ml/10 g, n = 12), from a previous experiment,
were re analysed using the present approach.
3. Results
3.1. Experiment 1: Descriptive and principal components analysis of
Swiss mice behaviour during the FST
The latency for the ﬁrst occurrence and the frequency and duration
of behaviour within each category recorded during the FST are given in
Table 1. The active behaviours had shorter latencies than immobility.
Swimming and immobility were longer in duration and more frequent
than climbing.Minute-by-minute analysis (Fig. S1) showed that the fre-
quency of immobility (MANOVA, F (5,195) = 9.92, p b 0.05) increased
during the test, whereas the frequency of climbing behaviour declined
(MANOVA, F (5,195) = 11.45, p b 0.05). The same trend was observed
for the duration of each behaviour (MANOVA, immobility, F (5,195) =
36.51, p b 0.05; climbing, F (5,195) = 42.15, p b 0.05; Fig. S1). Param-
eters of swimming were relatively stable, i.e., did not change over time
(Fig. S1, MANOVA, Frequency: F (5,195) = 2, p > 0.05 and Duration: F
(5,195) = 36.51, p > 0.05).
Factorial analysis of the behavioural variables recorded during the
whole period of the test and Principal Component Analysis, according
to the criteria published elsewhere (Lino-de-Oliveira et al., 2005;
Mezadri et al., 2011), are shown in the Supplementary material (Tables
S1 and S2). Analysis revealed a three-factor proﬁle that accounted for
86% of the total variance: 1) component I, correlated with the latency
(EV = 0.8) and duration (EV = −0.93) of immobility and the duration
of swimming (EV = 0.86), 2) component II, correlated with the fre-
quency of immobility (EV = 0.85) and swimming (EV = 0.92) and
the duration of climbing (EV = −0.54), and 3) component III, correlat-
ed with the frequency (EV = −0.9) and duration (EV = 0.74) of
climbing.
3.2. Experiment 2: Effects of antidepressants on Swiss mice behaviour
during the FST
When the animals' behaviours were analysed throughout the whole
period of the test (6 min, Fig. 1A), there was a signiﬁcant effect of treat-
ment on the duration of immobility (1-way ANOVA, F (4,45) = 13.37;
p b 0.05), swimming (1-way ANOVA, F (4,45) = 3.742; p b 0.05) and
climbing (1-way ANOVA, F (4,45) = 22.41; p b 0.05). Bonferroni's test
(p b 0.05) revealed that, compared to saline, all drugs signiﬁcantly re-
duced the amount of time spent immobile while concomitantly increas-
ing the amount of time spent engaged in active behaviours (Fig. 1A).
Imipramine and desipramine signiﬁcantly increased the duration of
swimming whereas ﬂuoxetine and caffeine signiﬁcantly increased theTable 1
Overall frequency, duration, and latency of behavioural categories recorded in the FST
in Swiss mice.
Latency (s) Frequency Duration (s)
Climbing 17.8 ± 10.17 5.2 ± 0.59 69.35 ± 6.72
Swimming 21.92 ± 3.72 11.8 ± 0.64 147.57 ± 10.13
Immobility 79.65 ± 7.72 9.4 ± 0.53 142.87 ± 8.84
Values ± S.E.M. in 6 min of the FST. Number of cases = 40.duration of climbing (Fig. 1A). During the last 4 min (Fig. 1B), drug treat-
ment had a signiﬁcant effect on the duration of immobility (1-way
ANOVA, F (4, 45) = 9.6; p b 0.05), swimming (1-way ANOVA, F (4,
45) = 2.63; p b 0.05) and climbing (1-way ANOVA, F (4, 45) = 38.34;
p b 0.05). Post hoc analysis revealed similar results to those found in
the analysis of the 6-min session (Fig. 1B): 1-desipramine and caffeine
signiﬁcantly reduced (Bonferroni's test, p b 0.05) the amount of time
spent immobile while 2-signiﬁcantly increasing the frequency of swim-
ming and climbing, respectively, when compared with saline. During
the ﬁrst 2 min (Fig. 1C), the duration of immobility was signiﬁcantly re-
duced by antidepressant treatment (1-way ANOVA, F (4, 45) = 24.47;
post hoc p b 0.05). Imipramine and desipramine increased the amount
of time spent swimming (1-way ANOVA, F (4, 45) = 4.59, post hoc
p b 0.05), whereas caffeine increased the duration of climbing (1-way
ANOVA F (4, 45) = 5.05, post hoc p b 0.05) (Fig. 1C).
Caffeine increased the frequency of swimming and climbing when
analysed during the full 6 min period and the last 4 min (1-way
ANOVA, 6 min, swimming: F (4,45) = 7.72; p b 0.05, post hoc,
p b 0.05, climbing: F (4,45) = 22.41; p b 0.05, post hoc, p b 0.05;
4 min, swimming: F (4,45) = 5.81; p b 0.05, post hoc, p b 0.05,
climbing: F (4,45) = 15.6; p b 0.05, post hoc, p b 0.05; Fig. 2B). The
Fig. 2. Frequency (number of occurrences) of the immobility, swimming and climbing
recorded in the 6-min test session (A) or in the last for 4-min test session (B) or ﬁrst
2-min test session of Swiss mice-FST after the acute treatment (n = 10/group) with sa-
line (white bars), or imipramine (light grey bars), desipramine (grey bars), ﬂuoxetine
(dark grey bars) or caffeine (black bars). Bars represent mean ± S.E.M. One-way
ANOVA followed by Bonferroni's test, ⁎p b 0.05 in comparison to saline group.
Fig. 3. Duration (in seconds) of the immobility (A), swimming (B), and climbing (C) taken
minute byminute over the 6 min of Swissmice FST.Mice received saline (black triangles),
imipramine (white squares), desipramine (white circles), ﬂuoxetine (black squares) and
caffeine (black circles). On the X-axis are represented each minute evaluated (1, 2, 3, 4, 5
and 6, respectively). Data are expressed as means of 10 animals per group. S.E.M. bars
were suppressed in order to make graphs clearer. Two-Way ANOVA repeated measures
followed by Bonferroni's test, ⁎p b 0.05 in comparison to saline group.
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ANOVA, F (4,45) = 8.48; p b 0.05, post hoc, p b 0.05, Fig. 2C). Desipra-
mine and ﬂuoxetine increased the frequency of climbing signiﬁcantly
only when the full 6 min period of the test were evaluated (1-way
ANOVA, F (4,45) = 22.41; p b 0,05, post hoc, p b 0.05, Fig. 2A).
Latency to immobility was increased by all treatments (Kruskal–
Wallis, H = 18.35; p b 0.05, Dunn's test, p b 0.05, Fig. S2), whereas la-
tency to swimming and climbing did not change signiﬁcantly. Minute-
by-minute analysis revealed that, similar to antidepressant treatment,
caffeine reduced the duration of immobility during the ﬁrst minute of
the test when compared with saline (2-way ANOVA interaction
Treatment × Time, F (20,45) = 2.79; p b 0.05, post hoc, p b 0.05,
Fig. 3). In contrast to the effect of saline and the antidepressants, caf-
feine increased the duration and frequency of climbing from the ﬁrst
minute until the end of the test (2-way ANOVA, Treatment: F (4,
45) = 22.41, p b 0.05; Time: F (5, 45) = 48.94; p b 0.05; post hoc,
p b 0.05, Figs. 3 and 4). The effects of apomorphine on measures of
climbing were similar to those of caffeine (Supplementary material,
Figs. S3–S5).4. Discussion
The main results of the present work indicated that FST in Swiss
mice may be employed to discriminate antidepressants (SSRIs and
NSRIs) from stimulants of motor activity such as caffeine and apo-
morphine. Indeed, ﬂuoxetine (an SSRI), desipramine (an NSRI) and
stimulants of motor activity (caffeine and apomorphine) increased
scores (frequency and duration) of climbing, but only caffeine and
apomorphine increased these measures during the whole 6 min peri-
od. Moreover, it was conﬁrmed that the FST in Swiss mice is a suitable
paradigm for detecting the effects of SSRIs and NSRIs, but was unable
to discriminate between them.
Immobility during the FST in Swiss mice has been suggested as one
of the ﬁrst preclinical measures to be evaluated when screening new
antidepressants (Bourin et al., 2005). The test is valuable because, in
contrast to other strains, the immobility of Swiss mice during the FST
is consistently reduced by several different antidepressants, excluding
Fig. 4. Frequency (number of occurrences) of the immobility (A), swimming (B), and
climbing (C) taken minute-by-minute over the 6 min of Swiss mice FST. Mice received
saline (white triangles), imipramine (white squares), desipramine (white circles), ﬂu-
oxetine (black squares) and caffeine (black circles). On the X-axis are represented each
minute evaluated (1, 2, 3, 4, 5 and 6, respectively). Data are expressed as means of 10
animals per group. S.E.M. bars were suppressed in order to make graphs clearer.
Two-way ANOVA repeated measures followed by Bonferroni's test, ⁎p b 0.05 in com-
parison to saline group.
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2003; Lucki et al., 2001). In the present work, naive male Swiss mice
exhibited low scores of immobility during the ﬁrst 2 min and low scores
of climbing during the last 4 min, while swimming seemed to be stable
throughout the test. This temporal proﬁle is similar to that observed
previously in mice (e.g. Castagné et al., 2009; Porsolt et al., 1977,
1978) and rats (e.g. Lino-de-Oliveira et al., 2005). Although intraperito-
neal injection of saline did not change this temporal proﬁle, it increased
the scores of immobility when compared to antidepressant-treated
mice in the ﬁrst 2 min. Hence, the difference in the amount of immobil-
ity between the saline and antidepressant groups was greater during
the ﬁrst 2 min (75–78% reduction with antidepressant treatment)
than in the more commonly used time period of the last 4 min of the
test (29–47% reduction). The difference measured during the ﬁrst
2 min was also larger than that measured during the whole period of
the FST (41–54% reduction). Although the magnitude of these differ-
ences is expected to vary with the type of control group (e.g., vehicle
or route of administration), the duration of immobility seems to bemore sensitive to antidepressants and caffeine when scored during
the ﬁrst 2 min of the FST than when scored during the last 4 min of
the test. These data are similar to those obtained with an automated
system examining male CD-1 mice in FST (Hayashi et al., 2011).
The duration, frequency and latency of immobility seem to repre-
sent different aspects of the behavioural strategies used by Swiss mice
during the FST because, according to PCA, the latency and duration of
immobility were correlated with a component distinct from that corre-
lated with the frequency of immobility. These factorial characteristics
were similar to those observed in rats (e.g. Lino-de-Oliveira et al.,
2005) and could indicate that the latency and duration of immobility
may be similarly sensitive to, but oppositely affected by, antidepressant
treatment. These results were shown in previous studies (e.g. Castagné
et al., 2009) and conﬁrmed in the present pharmacological experiment.
Castagné et al. (2009) also showed that NSRIs and serotonin–norepi-
nephrine reuptake inhibitors (e.g. tricyclic antidepressants like imipra-
mine), but not SSRIs or stimulants of motor activity, consistently
increased the latency but reduced the duration of immobility in NMRI
and C57BL6/J mice. Here, antidepressants as well as the caffeine in-
creased the latency to immobility while reducing its duration indicating
that latency to immobility should not be used to discriminate antide-
pressants from stimulants in Swiss mice during the FST.
The duration of immobility and swimmingwere oppositely correlat-
ed with a component identiﬁed by PCA, indicating that a reduction in
one of them (e.g., immobility) could happen concurrently with an in-
crease in the other (e.g., swimming). This example of opposing effects
on immobility and swimming is typically induced by SSRIs during the
FST in rats (e.g., Cryan et al., 2005;Detke et al., 1997; Lucki, 1997). In op-
position, NSRIs usually reduce immobility while increase climbing dur-
ing the FST in rats (e.g., Cryan et al., 2005; Detke et al., 1997; Lucki,
1997). These differences are used to discriminate SSRIs from NSRIs dur-
ing the FST in rats (e.g. Cryan et al., 2005; Detke et al., 1997; Lucki,
1997). This method seems not applicable to Swiss mice because SSRIs
and NSRIs tested in the present study produced similar behavioural
effects.
In addition, in contrast to rats (e.g. Lino-de-Oliveira et al., 2005),
Swiss mice exhibited frequencies of immobility and swimming during
the FST that were positively correlated with the same principal compo-
nent, whereas the duration of climbingwas negatively correlated. How-
ever, the pharmacological approach suggested that treatment did not
have opposing effects on these behavioural measures. Indeed, all anti-
depressants failed to affect the frequency of immobility (except when
the ﬁrst 2 min were analysed) while concomitantly increasing, or
tending to increase, the frequency of swimming and duration of
climbing. These results reinforce that the amount of time Swiss mice
spend climbing during the FST is not a suitablemeasure for differentiat-
ing NSRIs from other antidepressants, such as SSRIs, as has been previ-
ously suggested using the FST in rats (Cryan et al., 2005; Detke et al.,
1997; Lino-de-Oliveira et al., 2005). These conﬂicting ﬁndings of the
FST in rats and Swiss mice raises the intriguing possibility that the
monoaminergic mechanisms regulating active behaviours in Swiss
mice and rats may be different, a hypothesis that deserves further
investigation.
The duration and frequency of climbingweremore closely correlated
with a PCA component distinct from the other variables. Interestingly,
desipramine (NSRI) and ﬂuoxetine (SSRI) increased the frequency and
duration of climbing when they were analysed during the full 6 min of
the test. These effects disappeared when the measurements were
made during the ﬁrst 2 or the last 4 min. Caffeine and apomorphine, in
contrast, increased the frequency of climbing when analysed during ei-
ther the full 6 min or the last 4 min. Moreover, in contrast to desipra-
mine and ﬂuoxetine, stimulants increased the duration of climbing
during the whole period analysed. Indeed, the minute-by-minute analy-
sis revealed that caffeine, in contrast with antidepressants, increased the
duration of climbing from the third to sixth minute compared with the
saline group. Additionally, in contrast to antidepressants, caffeine kept
155A.P.R. Costa et al. / Progress in Neuro-Psychopharmacology & Biological Psychiatry 45 (2013) 150–155the frequency of climbing consistently high from the ﬁrst minute until
the end of the test. These data suggest that the amount of time spent
climbing may be a suitable parameter, distinguishing antidepressants
from stimulants of motor activity, when are scored during the last
4 min of the FST or minute-by-minute.
5. Conclusion
The present results suggest that the ﬁrst 2 min of the FST in Swiss
mice is a good window of time to evaluate the effects of antidepres-
sants on immobility. The last 4 min of the FST in Swiss mice provided
a suitable timeframe in which behaviour can be used to discriminate
the effects of antidepressants from stimulants of motor activity. Alto-
gether, our data show that the behavioural microstructure of Swiss
mice during the FST may help to delineate an innovative protocol to
predict the efﬁcacy of antidepressants. A simple procedural modiﬁca-
tion such as minute-by-minute analysis improved the predictability
of the test avoiding false positive results with stimulants of motor ac-
tivity. However, the reliability of the effects of standard drugs should
be veriﬁed using a larger range of doses and compounds.
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